UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2014
NEOPHOTONICS CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
DELAWARE |
|
001-35061 |
|
94-3253730 |
|
(State of incorporation) |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
NeoPhotonics Corporation
2911 Zanker Road
San Jose, California 95134
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (408) 232-9200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
ITEM 2.02 |
RESULTS OF OPERATIONS AND FINANCIAL CONDITION |
On November 10, 2014, NeoPhotonics Corporation (the “Company”) issued a press release regarding the Company’s financial results for the third quarter ended September 30, 2014. A copy of the Company’s press release is furnished and attached as Exhibit 99.1 to this Form 8-K.
The information in this Form 8-K and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.
|
ITEM 9.01 |
FINANCIAL STATEMENTS AND EXHIBITS. |
|
(d) |
Exhibits. |
|
Exhibit Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release issued by NeoPhotonics Corporation on November 10, 2014. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Date: November 10, 2014 |
|
NEOPHOTONICS CORPORATION |
||
|
|
|
|
||
|
|
|
By: |
|
/s/ Clyde R. Wallin |
|
|
|
|
|
Clyde R. Wallin |
|
|
|
|
|
Senior Vice President and Chief Financial Officer |
3
INDEX TO EXHIBITS
|
|
|
|
|
Exhibit Number |
|
Description |
|
|
|
|
|
99.1 |
|
Press Release issued by NeoPhotonics Corporation on November 10, 2014. |
4